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Abstract
Background. Depressive and anxiety disorders are highly comorbid, which has been theorized
to be due to an underlying internalizing vulnerability. We aimed to identify groups of
participants with differing vulnerabilities by examining the course of internalizing psycho-
pathology up to age 45.
Methods.We used data from 24158 participants (aged 45+) in 23 population-based cross-sec-
tional World Mental Health Surveys. Internalizing disorders were assessed with the
Composite International Diagnostic Interview (CIDI). We applied latent class growth analysis
(LCGA) and investigated the characteristics of identified classes using logistic or linear
regression.
Results. The best-fitting LCGA solution identified eight classes: a healthy class (81.9%), three
childhood-onset classes with mild (3.7%), moderate (2.0%), or severe (1.1%) internalizing
comorbidity, two puberty-onset classes with mild (4.0%) or moderate (1.4%) comorbidity,
and two adult-onset classes with mild comorbidity (2.7% and 3.2%). The childhood-onset
severe class had particularly unfavorable sociodemographic outcomes compared to the healthy
class, with increased risks of being never or previously married (OR = 2.2 and 2.0, p < 0.001),
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not being employed (OR = 3.5, p < 0.001), and having a low/low-average income (OR = 2.2,
p < 0.001). Moderate or severe (v. mild) comorbidity was associated with 12-month internal-
izing disorders (OR = 1.9 and 4.8, p < 0.001), disability (B = 1.1–2.3, p < 0.001), and suicidal
ideation (OR = 4.2, p < 0.001 for severe comorbidity only). Adult (v. childhood) onset was
associated with lower rates of 12-month internalizing disorders (OR = 0.2, p < 0.001).
Conclusions. We identified eight transdiagnostic trajectories of internalizing psychopath-
ology. Unfavorable outcomes were concentrated in the 1% of participants with childhood
onset and severe comorbidity. Early identification of this group may offer opportunities for
preventive interventions.
Introduction
Depressive and anxiety disorders are responsible for the largest
share of the global burden of disease due to mental disorders
(Kassebaum et al., 2016), as a consequence of their high preva-
lence, early age-of-onset (AOO), and chronic/recurrent course
(Bruce et al., 2005; Judd et al., 1998; Kessler et al., 2005a;
Penninx et al., 2011; Wardenaar, Conradi, & de Jonge, 2014).
Moreover, these disorders are often comorbid with one another
(Lahey, Zald, Hakes, Krueger, & Rathouz, 2014; Ormel et al.,
2015), and comorbidity is associated with worse outcomes than
pure disorders (Hendriks, Spijker, Licht, Beekman, & Penninx,
2013; Penninx et al., 2011).
High levels of comorbidity have been theorized to be due to a
shared, underlying vulnerability. Factor analyses aimed at identi-
fying an evidence-based structure of psychopathology have found
that depressive and anxiety disorders cluster together in an intern-
alizing dimension, while substance use disorders and behavioral
disorders cluster together in an externalizing dimension
(Krueger et al., 2018). These dimensions have been found to
explain almost all of the comorbidity between specific disorders
(Kessler et al., 2011). Intergenerational transmission of internaliz-
ing disorders (from parents to children) also appears to be pri-
marily transdiagnostic rather than disorder-specific (Starr,
Conway, Hammen, & Brennan, 2014). Thus, while the original
concept of comorbidity implies that people with comorbid disor-
ders have multiple, separate disorders, these lines of research sug-
gest instead that internalizing disorders reflect the same
underlying psychopathological process, although the specific clin-
ical manifestation varies between persons and across the life
course. For instance, major depressive disorder (MDD) is rare
in children, but specific phobia and social anxiety disorder com-
monly show an onset in this age group (Kessler et al., 2005a), and
children with these disorders have an increased risk of later devel-
oping depression (Lieb et al., 2016; Stein et al., 2001).
Research into transdiagnostic processes also suggests that
internalizing disorders share underlying mechanisms, such as
neuroticism or negative affectivity (Barlow, Sauer-Zavala, Carl,
Bullis, & Ellard, 2014). Furthermore, some processes originally
hypothesized to be relevant for a specific disorder, such as anxiety
sensitivity for panic disorder and rumination for MDD, appear to
be correlated with one another and more broadly involved in mul-
tiple internalizing disorders (Aldao, Nolen-Hoeksema, &
Schweizer, 2010; Hong & Cheung, 2015; Norton & Paulus,
2017). This has led to the development of transdiagnostic treat-
ments that target shared processes. Transdiagnostic treatments
have generally been found to be as effective as disorder-specific
treatments (Newby, McKinnon, Kuyken, Gilbody, & Dalgleish,
2015; Pearl & Norton, 2017).
These findings suggests that it could be worthwhile to focus
more attention on internalizing disorders as a group, as the specific
clinical manifestation may be less important to outcomes of inter-
est, such as disability, than a person’s general liability to internaliz-
ing disorders. Such a cross-disorder approach was common in early
epidemiological studies that conceptualized (common) mental ill-
ness as falling along a single continuum of severity, prior to the
development of the Diagnostic and Statistical Manual of Mental
Disorders, 3rd edition (DSM-III) and a greater focus on discrete
categories of mental disorder (Slade et al., 2015). More recently,
epidemiological studies have also commonly examined groups of
disorders instead of or in addition to specific disorders (e.g. de
Graaf, ten Have, van Gool, & van Dorsselaer, 2012; Nock,
Hwang, Sampson, & Kessler, 2010; Olfson et al., 2017), although
such groupings have often been based on a priori decisions (e.g.
grouping all anxiety disorders separately from mood disorders)
rather than empirical evidence.
However, previous research has not yet taken full advantage of
the parsimony of this model and the additional opportunities it
provides for exciting new analyses that examine the course of
internalizing psychopathology throughout life. In this paper, we
use latent class growth analysis (LCGA) to identify transdiagnos-
tic trajectories of internalizing psychopathology that are distinct
in terms of AOO or level of comorbidity. Subsequently, we inves-
tigate the associations between these trajectories and important
health outcomes including current psychopathology, disability,
suicidality, and treatment to examine the potential of this
approach to identify persons at high risk of poor outcomes.
Methods
Study sample
Data came from 23 cross-sectional, population-based surveys. Of
these surveys, four were administered in low/lower-middle-
income countries (Colombia, Iraq, Nigeria, and Peru), six in
upper-middle-income countries (Brazil, Bulgaria, Colombia
[Medellin], Lebanon, Mexico, and Romania), and 14 in high-
income countries (Argentina, Belgium, France, Germany, Italy,
Japan, the Netherlands, New Zealand, Northern Ireland,
Portugal, Spain, Spain [Murcia], and the USA), as classified by
the World Bank (World Bank, 2008). Respondents were adult
household residents. Respondent selection was based mainly on
multi-stage clustered area probability samples designed to
represent the household population of each country/region.
Interviews were conducted face-to-face in respondents’ homes.
The current analysis focuses on all respondents (n = 24.158)
who were 45 years or older at the time of the interview and
were interviewed about all relevant internalizing disorders. Four
surveys imposed an upper age limit on participation (at age 65),
while the other surveys had no upper age limit (see online
Supplemental Table 1 for further information about individual
surveys). Informed consent was obtained according to protocols
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endorsed by local Institutional Review Boards. Within-country
sampling methods are described in detail elsewhere (Heeringa
et al., 2008; Pennell et al., 2008).
Measures
Mental disorders
All mental disorders were assessed with the World Health
Organization (WHO) Composite International Diagnostic
Interview (CIDI), a fully-structured interview administered by
trained lay interviewers, which generates diagnoses according to
DSM-IV criteria (Kessler & Üstün, 2004). To reduce respondent
burden, interviews were administered in two parts. All respondents
completed Part I, which assesses core mental disorders. Part II,
which assesses other disorders and correlates, was administered
to all respondents with a lifetime Part I diagnosis and a probability
subsample of respondents without a lifetime Part I diagnosis. The
current study uses the Part II sample, which was weighted to adjust
for differential sub-sampling, so that weighted prevalence estimates
in the Part II sample are identical to those in the Part I sample.
The internalizing disorders included in the present study were
specific phobia, social anxiety disorder, generalized anxiety dis-
order (GAD), panic disorder, agoraphobia, post-traumatic stress
disorder (PTSD), and MDD. These diagnoses have shown gener-
ally good concordance with clinical diagnoses based on blinded
SCID reappraisal (Haro et al., 2006). AOO of each disorder was
assessed using special recall probes that yield more plausible
AOO distributions than conventional recall questions (Knäuper,
Cannell, Schwarz, Bruce, & Kessler, 1999).
Other measures
All respondents were asked about sociodemographic variables,
including educational level, marital status, employment status,
and income. They were also asked how many days they had
been completely unable to work due to physical or emotional
health reasons in the month before interview (days out of role)
and whether they had seriously thought about suicide, made a
suicide plan, or attempted suicide, in the 12 months before inter-
view. Finally, respondents were asked whether they had sought
treatment for problems with emotions, mental health, or the
use of alcohol or drugs in the past 12 months. Treatment was sub-
divided into four sectors: specialist mental health, general med-
ical, human services, and complementary or alternative medicine.
Statistical analyses
A person-year dataset for first onset of each disorder was built
using retrospectively-reported AOO of each disorder. Although
the CIDI assesses at which age symptoms were last present, it
does not assess non-symptomatic periods that may have occurred
between the AOO and the last age at which symptoms were pre-
sent. Therefore, we calculated the number of internalizing disor-
ders that had developed for each year in a participant’s life (up
to age 45), without regard for which disorders were actually active
in each year. We chose to examine the life course up to age 45 to
maintain a reasonable sample size while ensuring that most
internalizing disorders had already developed (65% of cases of
GAD or MDD to 97% of cases of social anxiety disorder in our
sample). Because few participants developed more than four dis-
orders by age 45 (0.3%), we used number of disorders as an
ordinal variable ranging from 0 to 4+ . We performed LCGA in
MPlus 8, with a class-specific intercept, slope, and quadratic
slope. The number of classes was decided upon based on the
sample-size-adjusted Bayesian Information Criterion (BIC),
while avoiding very small classes (<1% of participants).
Subsequent linear and (multinomial) logistic regression ana-
lyses to examine sociodemographic variables, disability, suicidal-
ity, and treatment were performed in SAS 9.4, using survey
procedures to account for the clustering and weighting of the
data. Regression was done using participants’ posterior probabil-
ities of belonging to each class. However, we also assigned parti-
cipants to their most likely class to obtain (marginal) percentages
and means for each class (e.g. for the percentage of women in
each class). Because the posterior probabilities were generally
very high (⩾90% for 98.5% of the sample), results using the
most likely class were highly similar to results using posterior
probabilities. In our main analyses, the ‘healthiest’ class was
used as a reference. However, to compare classes with internaliz-
ing psychopathology amongst each other, we also performed add-
itional regression analyses using each class’s AOO and severity
level [defined by the rounded mean number of internalizing dis-
orders developed by age 45 and categorized as mild (1 disorder),
moderate (2 disorders), and severe (3 or more disorders)] as sim-
ultaneous predictors. Sociodemographic analyses and marginal
percentages were adjusted for age, sex and country of origin of
the participant; all other analyses were adjusted only for country
of origin. We performed additional analyses by country income
level (low/middle income v. high income) and tested the inter-
action between class and country income level to investigate
possible cross-national variation. We set α = 0.005 (two-sided)
to reduce the likelihood of false positive results.
Results
Latent class growth analyses
We conducted latent class growth analyses with 2–10 classes (see
online Supplemental Table 2 for fit indices). The sample-size-
adjusted BIC decreased monotonously across this range, indicat-
ing better fit with more classes; however, solutions with >8 classes
included one or more very small classes (<1%) with similar trajec-
tories as higher-prevalence classes. We therefore selected the
8-class solution as the best solution. Entropy was very high
(0.997), indicating good separation of classes.
Figure 1 shows the mean number of internalizing disorders
over time for each class. Most participants (81.9%) were assigned
to a healthy class. Three classes showed onset of internalizing
psychopathology in childhood and we labelled these the child-
hood-onset severe (1.1%), childhood-onset moderate (2.0%),
and childhood-onset mild (3.7%) classes based on their AOO
and the severity level by age 45. Two classes had an onset during
puberty, of which one had moderate comorbidity (puberty-onset
moderate, 1.4%) and one low comorbidity (puberty-onset mild,
4.0%). Finally, the model identified an early-adult-onset mild
class (2.7%), which had onset at around age 30, and a middle-
adult-onset mild class (3.2%), which had onset at around age 40.
Disorder prevalence
We investigated which disorders were prevalent in each class
(Fig. 2). All percentages reported here refer to the percentage of
participants who had developed a specific disorder by age 45.
Childhood-onset classes were characterized by early specific
phobia (reported by 72.1–79.8%). The moderate and severe
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childhood-onset classes were further characterized by the early
onset of social anxiety disorder (reported by 46.2% and 74.0%,
respectively), with a later onset of other internalizing disorders,
especially MDD (45.5% and 66.0%, respectively). The
puberty-onset mild class most frequently developed specific pho-
bia (33.9%), social anxiety disorder (19.8%), or MDD (27.3%)
during puberty, with almost no further disorders developing in
adulthood. In the puberty-onset moderate class, specific phobia
Fig. 1. Distinct trajectories of internalizing psychopath-
ology up to age 45. Classes were identified through
latent class growth analysis; the trajectories display
the actual mean number of disorders by class when
respondents are assigned to their most likely class.
Fig. 2. Percentage of participants in each latent class who have developed each individual internalizing disorder from age 4 to 45.
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(35.0%) and social anxiety disorder (33.0%) were most frequent in
early puberty, but many members of this class later developed
MDD (70.5%), GAD (43.4%) or PTSD (32.9%). Finally, the
early-adult-onset and middle-adult-onset classes were character-
ized primarily by MDD (62.6% and 65.5%, respectively).
Sociodemographic outcomes
Table 1 shows the sociodemographic outcomes within each class
(see online Supplemental Table 3 for statistical tests). The healthy
class included the lowest percentage of females (51.2%) compared
to all other classes (58.8–72.7%, OR = 1.4–2.6, p < 0.001).
Compared to the healthy class, classes with internalizing psycho-
pathology also tended to be younger (participants aged 65 + :
10.5–22.6% v. 31.9%; participants aged 55–64: 26.0–31.8% v.
30.2%, OR = 1.4–2.6, p < 0.001; participants aged 45–54: 45.6–
63.4% v. 37.9%, OR = 1.7–5.0, p < 0.001).
Unfavorable sociodemographic outcomes were especially com-
mon in the childhood-onset severe class, which showed a higher
risk than the healthy class of being previously or never married
[OR = 2.2 (95% CI 1.7–2.9) and 2.0 (1.4–2.8), p < 0.001], having
an ‘other’ employment status (e.g. disabled, unemployed) [OR
= 3.5 (2.3–5.1), p < 0.001], and having a low or low-average
(rather than high) income [OR = 2.2 (1.6–3.1) and 2.2 (1.6–
3.0), p < 0.001]. All other internalizing classes also had an
increased risk of being previously married (OR = 1.4–1.7, p <
0.005). The childhood-onset moderate and puberty-onset mild
and moderate classes additionally had an increased risk of having
an ‘other’ employment status (OR = 1.7–2.3, p < 0.005).
Comparing internalizing classes amongst each other, we found
significant differences among severity levels in marital status,
employment status, and income category. Participants in the
severe class had greater risk than those in mild classes of being
never or previously married [OR = 2.2 (1.5–3.3) and 1.7 (1.2–
2.3), p < 0.005], having an ‘other’ employment status [OR = 2.7
(1.7–4.1), p < 0.001], and having a low or low-average income
[OR = 2.2 (1.5–3.2) and 2.2 (1.5–3.1), p < 0.001] (online
Supplemental Table 4). Controlling for severity, AOO was not sig-
nificantly associated with any sociodemographic characteristic.
Mental health outcomes
Participants in the healthy class rarely reported an active
12-month internalizing disorder (2.4%), but active 12-month dis-
orders were extremely common among childhood-onset classes
(69.4%, 79.4%, and 90.6% for mild, moderate, and severe classes,
OR = 99.4–474.6, p < 0.001) (Table 2). The early-adult-onset and
middle-adult-onset mild classes reported much lower rates of
12-month disorders (35.5% and 33.7%, OR = 21.1–23.2, p <
0.001), and puberty-onset classes reported intermediate rates
(52.0% and 66.5% for the mild and moderate classes, OR
= 45.8–88.1, p < 0.001). This was confirmed by our analyses
using AOO and severity as predictors, which found that puberty
or adult onset was associated with reduced risk of a 12-month
internalizing disorder [OR = 0.5 (0.4–0.6) and 0.2 (0.2–0.3), p
< 0.001], while moderate or severe comorbidity was associated
with increased risk of a 12-month internalizing disorder [OR
= 1.9 (1.6–2.2) and 4.8 (3.1–7.3), p < 0.001] (online
Supplemental Table 5).
The childhood-onset severe class reported the greatest number
of days out of role due to any mental or physical health reason in
the past month [mean (SE) = 4.0 (0.4)], which was significantly Ta
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higher than the mean (SE) of 1.4 (0.1) days out of role reported by
healthy participants [B = 2.6 (SE 0.4), p < 0.001] (Table 2). The
childhood-onset and middle-adult-onset mild classes reported
1.5 (0.2) and 1.9 (0.3) days out of role, which did not differ
from the healthy class ( p = 0.39 and 0.06). The puberty-onset
and early-adult-onset mild classes reported 2.2 (0.2) and 2.5
(0.3) days out of role, while the childhood-onset and
puberty-onset moderate classes reported 3.0 (0.3) and 3.0 (0.4)
(B = 0.8–1.7, p < 0.001). Participants in moderate or severe classes
reported significantly more days out of role than those in mild
classes [B = 1.1 (SE 0.3) and 2.3 (SE 0.5), p < 0.001], while AOO
was not a significant predictor (online Supplemental Table 6).
With regard to 12-month suicidality (Table 3), all internalizing
classes were more likely than the healthy class to report ideation
(3.0–13.6% v. 0.7%, OR = 4.5–21.7, p < 0.001), suicidal plans (0.8–
3.5% v. 0.1%, OR = 6.6–31.2, p < 0.001), or suicide attempts (0.4–
1.8% v. 0.1%, OR = 5.3–31.9, p < 0.005) than the healthy class.
The risk of suicidality was strongly associated with level of
comorbidity, with the severe class being more likely to report sui-
cidal ideation [OR = 4.2 (2.7–6.6), p < 0.001] and both moderate
and severe classes being more likely to report suicidal plans [OR
= 2.3 (1.3–4.0) and 4.0 (2.0–8.3), p < 0.005] than mild classes,
although there was no significant association for suicide attempts.
AOO was not significantly associated with 12-month suicidality
(online Supplemental Table 7).
All internalizing classes were more likely than the healthy class
to report receiving treatment for mental health problems in the
past 12 months, in any sector (18.2–49.4% v. 5.9%, OR = 3.4–
13.4, p < 0.001) as well as in each specific sector (online
Supplemental Table 8). Receiving treatment was strongly asso-
ciated with severity, with both moderate and severe classes
being more likely to receive any treatment [OR = 2.5 (2.1–3.0)
and 3.9 (3.1–4.9) respectively, p < 0.001], as well as treatment in
specific sectors (online Supplemental Table 9). Receiving any
treatment was also associated with AOO, with adult-onset classes
having a higher likelihood of receiving any treatment than
childhood-onset classes [OR = 1.5 (1.2–1.8), p < 0.001], although
this association was not significant for any specific treatment
sector.
Low/middle-income v. high-income countries
There was a significant difference in prevalence of the different
classes between low/middle-income v. high-income countries
Table 2. 12-month active internalizing disorders and days out of role in the past month, by class
Class N
Active 12-month internalizing disorder Days out of role in the past month
% (SE) OR (95% CI) Mean (SE) B (SE)
Healthy 16 871 2.4 (0.1) 1.0 1.4 (0.1) 0.0
Mild Childhood onset 1 322 69.4 (1.8) 99.4 (82.1–120.2)** 1.5 (0.2) 0.1 (0.2)
Puberty onset 1 528 52.0 (1.8) 45.8 (38.5–54.5)** 2.5 (0.3) 1.2 (0.3)**
Early-adult onset 1 152 35.5 (1.9) 23.2 (19.1–28.3)** 2.2 (0.2) 0.8 (0.2)**
Middle-adult onset 1 334 33.7 (1.8) 21.1 (17.5–25.4)** 1.9 (0.3) 0.5 (0.3)
Moderate Childhood onset 861 79.4 (1.7) 183.0 (143.8–233.0)** 3.0 (0.3) 1.7 (0.3)**
Puberty onset 604 66.5 (2.3) 88.1 (69.7–111.3)** 3.0 (0.4) 1.7 (0.4)**
Severe Childhood onset 486 90.6 (1.7) 474.6 (315.8–713.0)** 4.0 (0.4) 2.6 (0.4)**
Percentages are weighted percentages derived from cross-tabulation. Tests were based on logistic regression (for the outcome of having a 12-month active internalizing disorder) or linear
regression (for the outcome of days out of role in the past month) using the posterior probabilities of class membership to predict the outcome. All analyses controlled for the country of
origin of the participant. * p < 0.005 ** p < 0.001.
Table 3. 12-month suicidality reported by each class
Class N
Ideation Plan Attempt
% (S.E.) OR (95% CI) % (S.E.) OR (95% CI) % (S.E.) OR (95% CI)
Healthy 16 871 0.7 (0.1) 1.0 0.1 (0.0) 1.0 0.1 (0.0) 1.0
Mild Childhood onset 1 322 3.3 (0.7) 4.5 (2.7–7.4)** 0.9 (0.3) 6.6 (3.5–12.4)** 0.6 (0.2) 7.7 (2.6–23.0)**
Puberty onset 1 528 3.6 (0.5) 5.1 (3.6–7.4)** 1.0 (0.3) 7.7 (4.1–14.7)** 0.4 (0.2) 5.3 (1.7–16.7)*
Early-adult onset 1 152 3.4 (0.6) 4.8 (3.2–7.3)** 1.2 (0.3) 9.7 (5.2–18.1)** 0.7 (0.3) 9.8 (3.2–30.3)**
Middle-adult onset 1 334 3.0 (0.8) 4.3 (2.4–7.6)** 0.8 (0.3) 6.7 (3.3–13.6)** 0.5 (0.2) 7.7 (2.8–20.9)**
Moderate Childhood onset 861 6.6 (0.9) 9.5 (6.6–13.7)** 2.4 (0.6) 18.5 (9.8–34.6)** 1.0 (0.3) 13.5 (5.1–36.0)**
Puberty onset 604 4.1 (0.9) 5.7 (3.6–9.3)** 1.7 (0.5) 12.9 (6.9–24.2)** 0.6 (0.2) 8.2 (3.0–22.5)**
Severe Childhood onset 486 13.6 (1.8) 21.7 (15.1–31.2)** 3.5 (0.9) 31.2 (16.5–59.0)** 1.8 (0.6) 31.9 (13.5–75.7)**
Percentages are weighted percentages derived from cross-tabulation. Tests were based on logistic regression with suicidality as an outcome and the posterior probabilities of class membership
as predictors, controlling for country of origin of respondents. N = unweighted sample size per class (when respondents are assigned to their most likely class). * p < 0.005 ** p < 0.001.
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[χ2 (7) = 138.7, p < 0.001], with the healthy class being more
prevalent in low/middle-income countries than in high-income
countries (85.5% v. 80.0%) and the internalizing classes being
less prevalent (online Supplemental Table 10). However, the
rank order of prevalence was generally preserved. While there
were differences in the prevalence of certain outcomes (e.g. treat-
ment rates), associations between class membership and
sociodemographic variables, active 12-month disorders, disability,
suicidality, and treatment were generally similar in low/
middle-income and high-income countries, with few significant
interaction terms (see online Supplemental Tables 11–23).
Discussion
In this large cross-national survey, we identified transdiagnostic
trajectories of internalizing psychopathology by examining the
number of internalizing disorders developing up until age 45.
Around 18% of our sample developed at least one internalizing
disorder and these respondents could be classified into seven
classes that showed varying ages of onset and levels of comorbid-
ity. The three childhood-onset classes were characterized by the
early onset of specific phobia; moderate and severe
childhood-onset classes also showed high rates of early-onset
social anxiety disorder and often developed MDD or other intern-
alizing disorders later in life. Adult-onset classes, in contrast, usu-
ally only developed MDD, while puberty-onset classes showed a
mixed, intermediate pattern.
Classes with internalizing psychopathology were more likely to
be female than the healthy class, consistent with a wealth of pre-
vious research (Steel et al., 2014). They also tended to be younger.
Although this might suggest that younger generations are more
likely to develop mental health problems, this finding might
also be due to recall bias, with older generations being more likely
to forget symptoms that they suffered earlier in life. There were
relatively few other sociodemographic differences between the
classes, although all internalizing classes were more likely to be
previously (rather than currently) married than the healthy
class. Surprisingly, educational outcomes did not differ between
classes, despite early onset of internalizing disorders in some
classes. However, unfavorable sociodemographic outcomes,
including a low income and an ‘other’ employment status (e.g.
being disabled or unemployed), were clearly concentrated in the
childhood-onset severe class.
Compared to the healthy class, all the internalizing classes
showed negative mental health outcomes, reporting higher rates
of active 12-month internalizing disorders, suicidality, and, for
most classes, disability. Internalizing classes also had higher
12-month treatment rates. Furthermore, classes with moderate
or severe comorbidity consistently had worse outcomes than
classes with mild comorbidity. Controlling for severity, AOO
was only associated with the prevalence of active 12-month
internalizing disorders and with treatment in any sector. The for-
mer may be related to the specific disorders present in
childhood-onset v. adult-onset classes [e.g. specific phobia, a
highly persistent disorder (Wardenaar et al., 2017) v. MDD, a
more episodic disorder (Bromet et al., 2011)].
We are aware of only two other studies that have traced trajec-
tories of internalizing problems over a larger portion of the life-
span (Colman, Ploubidis, Wadsworth, Jones, & Croudace, 2007;
Paksarian et al., 2016), although growth analysis has been used
more frequently to analyze the course of internalizing symptom-
atology in children and adolescents (Edwards et al., 2014; Fanti &
Henrich, 2010; Klein et al., 2019; Nivard et al., 2017; Olino, Stepp,
Keenan, Loeber, & Hipwell, 2014; Prinzie, van Harten, Dekovic,
van den Akker, & Shiner, 2014; Sterba, Prinstein, & Cox, 2007;
Weeks et al., 2014). Colman et al. (2007) analyzed a longitudinal
dataset (n = 4627), in which participants’ current level of depres-
sion and anxiety was assessed five times between the ages of 13
and 53 (Colman et al., 2007). The best-fitting model included a
large healthy class, an adolescence-limited class, two adoles-
cent-onset persistent classes, and two adult-onset classes.
Paksarian et al. (2016) also analyzed a longitudinal dataset (n
= 591), in which participants were assessed for the past-year
presence of psychiatric disorders seven times between the ages
of 20 and 50 (Paksarian et al., 2016). The best-fitting model
for having any mood or anxiety disorder included a large
healthy class; a large class with gradually increasing risk; and a
small class in which risk initially increased and subsequently
decreased. In contrast to our own work, these studies, based
on longitudinal data, could model not just development of
symptoms but also recovery. However, neither study covered
childhood, and they also did not examine whether particular
classes were associated with poor health outcomes.
Furthermore, Paksarian et al. (2016) examined the probability
of having any mood or anxiety disorder, while Colman et al.
(2007) examined symptom levels rather than diagnosable disor-
ders. Consequently, neither study is informative with regard to
the development of internalizing comorbidity.
Our results show that unfavorable outcomes are highly con-
centrated in the 1.1% of respondents who reported childhood
onset and high levels of comorbidity. Hence, efforts to reduce
the burden of mental illness may be most efficient if targeted at
this class of people. In our study, this class was characterized by
the early co-occurrence of specific phobia and social anxiety dis-
order, and it would be valuable to further investigate predictors of
poor-outcome trajectories. For instance, among children who
have already developed specific phobia, can we identify which
children will go on to develop other internalizing disorders? In
previous research, we found that childhood generalized specific
phobia (i.e. having multiple phobias) is associated with particu-
larly unfavorable outcomes, even compared to those reporting
only a single specific phobia (De Vries et al., 2019), and it is pos-
sible that generalized phobia would differentiate between the
childhood-onset mild class and the childhood-onset moderate
or severe classes. Other predictors, such as childhood adversities,
parental socioeconomic status, or family history, might also be
highly relevant.
In this study, we did not consider externalizing disorders, due
to the limitations of the dataset. Specifically, most countries only
assessed behavioral disorders (e.g. attention deficit hyperactivity
disorder, oppositional-defiant disorder, and conduct disorder)
in young participants (<45 years old); hence, these disorders
were not assessed in the included participants. While substance
use disorders were assessed in older participants, we felt that
these, by themselves, were not fully representative of the external-
izing spectrum. However, we know from previous research that
comorbidity between internalizing and externalizing disorders is
also common (Kessler, Chiu, Demler, & Walters, 2005b), and
studying the simultaneous trajectories of internalizing and exter-
nalizing psychopathology could therefore also be highly inform-
ative. To our knowledge, this work has only been done in
children and adolescents; it suggests that internalizing and exter-
nalizing trajectories are correlated, although ‘pure’ internalizing
and externalizing trajectories are also common (Chen &
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Simons-Morton, 2009; Fanti & Henrich, 2010; Nivard et al., 2017;
Reinke, Eddy, Dishion, & Reid, 2012).
Strengths and limitations
The main strength of this study is that we used a large cross-
national survey, including about 24.000 participants. This gave
us enough power to identify and examine the characteristics of
small classes. We also investigated a crucial period of life, covering
the median ages of onset of all internalizing disorders. Disorders
were assessed with a structured interview (CIDI), which has
shown moderate-to-good concordance with standardized clinical
assessments (Haro et al., 2006), rather than through symptom
questionnaires.
The primary limitation of the study is that the data were
derived from a cross-sectional interview. While special recall
probes were used that yield more plausible distributions of
AOO (Knäuper et al., 1999), some recall bias undoubtedly per-
sists. Consistent with this, we found that the healthy class was sig-
nificantly older than the internalizing classes. It is also possible
that people with high symptom levels at the time of interview
are more likely to recall symptoms experienced earlier in life,
which could potentially lead to spurious associations between
the latent trajectory classes and 12-month outcomes. We have
previously found that associations between childhood specific
phobia and lifetime outcomes were present among people with
and without psychopathology at the time of interview (De Vries
et al., 2019), suggesting that current symptomatology cannot
fully explain the association between childhood symptoms and
later outcomes. Prospective research has also found consistent
associations between childhood-onset disorders and later out-
comes (e.g. Lieb et al., 2016); this triangulation [evidence from
multiple approaches, each with their own strengths and limita-
tions (Munafò & Davey Smith, 2018)] helps support the plausibil-
ity of our findings. However, we cannot fully exclude the
possibility that the associations we describe are a consequence
of recall bias. The CIDI also provides little information about
the longitudinal course of symptoms after onset of a disorder;
hence, we could not distinguish between respondents with persist-
ently high levels of comorbidity and respondents that recovered or
showed a more episodic course. To confirm and extend our find-
ings, it would be of interest to perform similar analyses in a pro-
spective cohort, although few such cohorts have a sufficiently
large sample size and long enough follow-up duration to approxi-
mate the analyses we have performed here. Secondly, while we
studied the age range in which most internalizing disorders first
develop, additional adult-onset trajectories might be discovered
if a longer timespan could be studied. We also did not include
all disorders that are sometimes considered to be part of the
internalizing spectrum (e.g. eating disorders), as these were only
assessed in a subset of respondents. Thirdly, it is possible that
comorbidity merely reflects a high total symptom count and
that a person with, for instance, many symptoms of depression
only would have similarly poor outcomes as a person with a
few symptoms of several different disorders. However, because
the CIDI does not assess all symptoms in participants who do
not report criterion symptoms (e.g. depressed mood or loss of
interest for MDD), we are unable to calculate a total symptom
count to investigate this possibility. Finally, we note that the sep-
aration into eight classes should be considered a pragmatic choice
rather than a reflection of some real-world mechanism, as we
expect that the underlying distributions are continuous rather
than discrete. However, the trajectories serve to highlight the
importance of AOO and level of comorbidity in predicting
unfavorable outcomes.
Conclusions
In this large, cross-national survey, we identified eight distinct
transdiagnostic trajectories of internalizing psychopathology
across the lifespan up to age 45. Although all classes with intern-
alizing psychopathology had worse health outcomes than the
healthy class, poor outcomes were especially highly concentrated
in the 1% of participants with childhood onset and high
comorbidity, who had increased risks of unfavorable sociodemo-
graphic outcomes as well as high rates of active 12-month disor-
ders, disability, suicidality, and treatment. These findings show
the importance of taking a transdiagnostic and life-course-
oriented approach to psychopathology, as opposed to a disorder-
and episode-specific approach. They also suggest that increased
clinical attention to young people likely belong to the high-risk
group, for instance children presenting with both specific phobia
and social anxiety disorder, may be warranted. Further investiga-
tion of the correlates and predictors of membership in this high-
risk class may offer opportunities for preventive interventions.
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